Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2015, Article ID 480764, 8 pages
http://dx.doi.org/10.1155/2015/480764
Research Article

Molecular Docking of Potential Inhibitors for Influenza H7N9

Medical College, Hunan Normal University, Changsha, Hunan 410013, China

Received 17 November 2014; Revised 22 February 2015; Accepted 22 February 2015

Academic Editor: Irini Doytchinova

Copyright © 2015 Zekun Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Gao, B. Cao, Y. Hu et al., “Human infection with a novel avian-origin influenza A (H7N9) virus,” The New England Journal of Medicine, vol. 368, no. 20, pp. 1888–1897, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Wang, Z. Dai, H. Cheng et al., “Towards a better understanding of the novel avian-origin H7N9 influenza A virus in China,” Scientific Reports, vol. 3, article 2318, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Chen, W. Liang, S. Yang et al., “Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: Clinical analysis and characterisation of viral genome,” The Lancet, vol. 381, no. 9881, pp. 1916–1925, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. Q. Liu, L. Lu, Z. Sun, G.-W. Chen, Y. Wen, and S. Jiang, “Genomic signature and protein sequence analysis of a novel influenza A(H7N9) virus that causes an outbreak in humans in China,” Microbes and Infection, vol. 15, no. 6-7, pp. 432–439, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. Treanor, F. G. Hayden, P. S. Vrooman et al., “Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial,” The Journal of the American Medical Association, vol. 283, no. 8, pp. 1016–1024, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. S.-Y. Chang, P.-H. Lin, J.-C. Tsai, C.-C. Hung, and S.-C. Chang, “The first case of H7N9 influenza in Taiwan,” The Lancet, vol. 381, no. 9878, p. 1621, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. Li, L. Zhou, M. Zhou et al., “Epidemiology of human infections with avian influenza A(H7N9) virus in China,” The New England Journal of Medicine, vol. 370, pp. 520–532, 2014. View at Publisher · View at Google Scholar
  8. X. Liu, T. Li, Y. Zheng, K.-W. Wong, S. Lu, and H. Lu, “Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection,” Emerging Microbes & Infections, vol. 2, article e27, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Lu, Y. Zheng, T. Li et al., “Clinical findings for early human cases of influenza A(H7N9) virus infection, Shanghai, Shina,” Emerging Infectious Diseases, vol. 19, no. 7, pp. 1142–1146, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Wu, Y. Bi, C. J. Vavricka et al., “Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses,” Cell Research, vol. 23, no. 12, pp. 1347–1355, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. G. R. Marshall, “Computer-aided drug design,” Annual Review of Pharmacology and Toxicology, vol. 27, pp. 193–213, 1987. View at Publisher · View at Google Scholar · View at Scopus
  12. G. M. Morris, H. Ruth, W. Lindstrom et al., “Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility,” Journal of Computational Chemistry, vol. 30, no. 16, pp. 2785–2791, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Wang, W. Jia, and A. Zhao, “Anti-influenza agents from plants and traditional Chinese medicine,” Phytotherapy Research, vol. 20, no. 5, pp. 335–341, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Thangasamy, S. Sittadjody, S. Lanza-Jacoby, P. R. Wachsberger, K. H. Limesand, and R. Burd, “Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase,” Nutrition and Cancer, vol. 59, no. 2, pp. 258–268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Primikyri, M. V. Chatziathanasiadou, E. Karali et al., “Direct binding of Bcl-2 family proteins by quercetin triggers its pro-apoptotic activity,” ACS Chemical Biology, vol. 9, no. 12, pp. 2737–2741, 2014. View at Publisher · View at Google Scholar
  16. C. Wu, H. Luan, X. Zhang et al., “Chlorogenic acid protects against atherosclerosis in ApoE−/− mice and promotes cholesterol efflux from RAW264.7 macrophages,” PLoS ONE, vol. 9, no. 9, Article ID e95452, 2014. View at Publisher · View at Google Scholar
  17. E. Heitman and D. K. Ingram, “Cognitive and neuroprotective effects of chlorogenic acid,” Nutritional Neuroscience, 2014. View at Publisher · View at Google Scholar
  18. M.-J. Hour, S.-H. Huang, C.-Y. Chang et al., “Baicalein, ethyl acetate, and chloroform extracts of Scutellaria baicalensis inhibit the neuraminidase activity of pandemic 2009 H1N1 and seasonal influenza A viruses,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 750803, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-J. Hsieh, K. Hall, T. Ha, C. Li, G. Krishnaswamy, and D. S. Chi, “Baicalein inhibits IL-1beta- and TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kappaB pathway,” Clinical and Molecular Allergy, vol. 5, article 5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Liu, L. Zheng, L. Ma et al., “Oleanolic acid inhibits proliferation and invasiveness of Kras-transformed cells via autophagy,” The Journal of Nutritional Biochemistry, vol. 25, no. 11, pp. 1154–1160, 2014. View at Publisher · View at Google Scholar
  21. J. Liu, X. Wang, R. Liu et al., “Oleanolic acid co-administration alleviates ethanol-induced hepatic injury via Nrf-2 and ethanol-metabolizing modulating in rats,” Chemico-Biological Interactions, vol. 221, pp. 88–98, 2014. View at Publisher · View at Google Scholar
  22. P. W. Rose, A. Prli , C. Bi et al., “The RCSB Protein Data Bank: views of structural biology for basic and applied research and education,” Nucleic Acids Research, vol. 43, no. D1, pp. D345–D356, 2015. View at Publisher · View at Google Scholar
  23. W. L. DeLano, The PyMOL Molecular Graphics System, DeLano Scientific, Palo Alto, Calif, USA, 2002.
  24. J. J. Irwin and B. K. Shoichet, “ZINC—a free database of commercially available compounds for virtual screening,” Journal of Chemical Information and Modeling, vol. 45, no. 1, pp. 177–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. Irwin, T. Sterling, M. M. Mysinger, E. S. Bolstad, and R. G. Coleman, “ZINC: a free tool to discover chemistry for biology,” Journal of Chemical Information and Modeling, vol. 52, no. 7, pp. 1757–1768, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Xu, X. Zhu, R. A. Dwek, J. Stevens, and I. A. Wilson, “Structural characterization of the 1918 influenza virus H1N1 neuraminidase,” Journal of Virology, vol. 82, no. 21, pp. 10493–10501, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. P. M. Mitrasinovic, “Advances in the structure-based design of the influenza A neuraminidase inhibitors,” Current Drug Targets, vol. 11, no. 3, pp. 315–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Gong, W. Xu, and J. Zhang, “Structure and functions of influenza virus neuraminidase,” Current Medicinal Chemistry, vol. 14, no. 1, pp. 113–122, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Lagorce, J. Maupetit, J. Baell et al., “The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections,” Bioinformatics, vol. 27, no. 14, Article ID btr333, pp. 2018–2020, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. B. E. Davies, “Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations,” The Journal of Antimicrobial Chemotherapy, vol. 65, supplement 2, pp. ii5–ii10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Liu, “Pharmacology of oleanolic acid and ursolic acid,” Journal of Ethnopharmacology, vol. 49, no. 2, pp. 57–68, 1995. View at Publisher · View at Google Scholar · View at Scopus